Literature DB >> 222512

Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies.

M Lopes-Virella, G Virella, M Debeukelaer, C J Owens, J A Colwell.   

Abstract

Serum lipids and lipoproteins and urinary apolipoprotein A (Apo A) were determined in two groups of patients. One group consisted of 11 children (ages ranging from 4 to 14 years) with minimal change glomerular disease. The other group consisted of 13 patients, eight less than 19 years old five adults, with different types of chronic glomerulopathy. Elimination of urinary lysozyme was a feature of chronic glomerulopathies, and creatinine clearances were also significantly lower in this group. Patients with chronic glomerulopathies had significantly lower HDL cholesterol and Apo A concentrations in their sera. In contrast, urinary Apo A concentrations were significantly higher in patients with chronic glomerulopathies, who also showed significantly lower urinary protein selectivities. Lipoprotein electrophoresis of urines containing Apo A showed distinct high-density lipoprotein (HDL) fractions, suggesting that HDL is eliminated in the urine as a result of increased glomerular permeability. This is also supported by a correlation coefficient of 0.77 between the selectivity indices and the ratio of urinary Apo A to total proteinuria. The determination of urinary Apo A appears to give valuable diagnostic information in patients with glomerular disease. According to our results the absence of urinary Apo A is very suggestive of minimal change glomerular disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222512     DOI: 10.1016/0009-8981(79)90187-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Effect of methylprednisolone therapy on lipoprotein metabolism in human nephrotic syndrome.

Authors:  L Kuzemková; J Stríbrná; J Kovár; R Poledne; K Matousovic
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 2.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01

Review 3.  Acute myocardial infarction in a young boy with nephrotic syndrome: a case report and review of the literature.

Authors:  L Hopp; N Gilboa; G Kurland; N Weichler; T J Orchard
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

4.  Lipoprotein profiles at different stages of the nephrotic syndrome.

Authors:  U Querfeld; A Gnasso; W Haberbosch; J Augustin; K Schärer
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.